BlackRock »

Titan Pharmaceuticals Inc Del shares owned by BlackRock

Quarter-by-quarter ownership of Titan Pharmaceuticals Inc Del shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Titan Pharmaceuticals Inc Del

Tip: Access up to 7 years of quarterly data

All positions including Titan Pharmaceuticals Inc Del held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Titan Pharmaceuticals Inc Del by BlackRock

Quarter filed Position value Share count Share price at filing
2025-09-30 $28 6 4.83
2025-06-30 $25 6 4.17
2025-03-31 $21 6 3.50

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Netflix (NFLX)

View all positions for BlackRock

Top funds holding Titan Pharmaceuticals Inc Del

DRW Holdings
UBS Group
Tower Research Capital
CoreCap Advisors
Group One Trading
Advisor Group Holdings
BlackRock
Morgan Stanley
Global Wealth Strategies & Associates
Caldwell Sutter Capital
Ransom Advisory
D. J. St. Germain
CWM
SBI Securities
Westside Investment Management

View all funds holding Titan Pharmaceuticals Inc Del